Evommune
Biotechnology ResearchCalifornia, United States51-200 Employees
Evommune is a clinical-stage biotechnology company based in Palo Alto, California, focused on developing therapies for chronic inflammatory diseases. It pursues discovery and development programs that target key drivers of chronic inflammation, with the aim of improving patients' daily lives and preventing long-term complications linked to insufficient inflammation control. Operating within the biotechnology research industry, the company positions itself as advancing therapies through clinical development. As a mid-sized organization, Evommune brings together a focused team to translate inflammatory biology into potential treatments. Recent updates note a Phase 2a readout for the EVO301 program. The company also indicated progress toward top-line Phase 2b data across its chronic inflammation portfolio. These milestones illustrate ongoing clinical development in the field of chronic inflammatory diseases.
1-888-653-2347 
support@leadiq.com 
